Cohen Capital Management’s Moderna MRNA Stock Holding History

Cohen Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	+3,470	New	+$180K	0.03%	145
2025 Q4	–	Sell	-9,072	Closed	-$234K	–	154
2025 Q3	$234K	Sell	9,072 -1,273	-12%	-$35.5K	0.04%	139
2025 Q2	$285K	Sell	10,345 -593	-5%	-$15.6K	0.05%	139
2025 Q1	$310K	Hold	10,938	–	–	0.05%	130
2024 Q4	$455K	Buy	10,938 +1,984	+22%	+$94.8K	0.08%	118
2024 Q3	$598K	Sell	8,954 -288	-3%	-$26.4K	0.1%	114
2024 Q2	$1.1M	Hold	9,242	–	–	0.19%	88
2024 Q1	$985K	Buy	9,242 +242	+3%	+$24.4K	0.17%	89
2023 Q4	$895K	Hold	9,000	–	–	0.17%	88
2023 Q3	$930K	Hold	9,000	–	–	0.19%	88
2023 Q2	$1.09M	Hold	9,000	–	–	0.21%	84
2023 Q1	$1.38M	Hold	9,000	–	–	0.28%	77
2022 Q4	$1.62M	Hold	9,000	–	–	0.33%	72
2022 Q3	$1.06M	Hold	9,000	–	–	0.23%	85
2022 Q2	$1.29M	Hold	9,000	–	–	0.26%	87
2022 Q1	$1.55M	Buy	+9,000	New	+$1.52M	0.27%	87

Other funds holding MRNA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

REX Advisers Fairfield, Connecticut $44.3M AUM

BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return

Quattro Financial Advisors The Woodlands, Texas $468M AUM 13.49% 1-Year Est. Return